Grove Bank & Trust Novartis Ag Transaction History

Grove Bank & Trust

$843 Million
Q3 2025

A detailed history of Grove Bank & Trust transactions in Novartis Ag stock. As of the latest transaction made, Grove Bank & Trust holds 752 shares of NVS stock, worth $98,925. This represents 0.01% of its overall portfolio holdings.

Number of Shares

752

Previous 1,018 26.13%

Holding current value

$98,925

Previous $123,000 21.95%

% of portfolio

0.01%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 06, 2025	SELL	$113.5 - $129.73 $30,191 - $34,508	-266 Reduced 26.13%	752 $96,000
Q2 2025 Jul 10, 2025	BUY	$101.96 - $121.01 $1,325 - $1,573	13 Added 1.29%	1,018 $123,000
Q1 2025 Apr 17, 2025	SELL	$97.14 - $115.57 $3,982 - $4,738	-41 Reduced 3.92%	1,005 $112,000
Q4 2024 Jan 16, 2025	SELL	$96.78 - $117.18 $17,130 - $20,740	-177 Reduced 14.47%	1,046 $101,000
Q3 2024 Oct 11, 2024	BUY	$106.13 - $120.89 $35,235 - $40,135	332 Added 37.26%	1,223 $140,000

Q2 2024 Jul 24, 2024	SELL	$92.57 - $107.37 $1,758 - $2,040	-19 Reduced 2.09%	891 $94,000
Q1 2024 Apr 30, 2024	BUY	$95.27 - $108.47 $1,429 - $1,627	15 Added 1.68%	910 $88,000
Q4 2023 Jan 30, 2024	SELL	$92.27 - $101.54 $369 - $406	-4 Reduced 0.44%	895 $90,000
Q3 2023 Oct 30, 2023	SELL	$94.73 - $105.13 $4,262 - $4,730	-45 Reduced 4.77%	899 $91,000
Q2 2023 Jul 27, 2023	SELL	$92.52 - $104.91 $462 - $524	-5 Reduced 0.53%	944 $95,000
Q1 2023 May 10, 2023	BUY	$80.03 - $92.81 $2,801 - $3,248	35 Added 3.83%	949 $87,000
Q4 2022 Feb 03, 2023	BUY	$75.55 - $92.52 $69,052 - $84,563	914 New	914 $83,000
Q4 2017 Feb 02, 2018	SELL	$72.33 - $77.64 $43,904 - $47,127	-607 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $45,002 - $46,902	607	607 $52,000

Others Institutions Holding NVS

# of Institutions

1,603

Shares Held

137M

Call Options Held

1.53M

Put Options Held

2.22M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $283B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.

Account